A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Explore 11592 conditions in our directory, and growing.
Condition name for this article.

HIV-1 pre-exposure prophylaxis

Other Names: PrEP, HIV PrEP, Pre-exposure prophylaxis, HIV pre-exposure prophylaxis, Pre-exposure prophylaxis for HIV, Pre-exposure prophylaxis against HIV infection, Chemoprophylaxis for HIV.
Causes Symptoms Treatment Prognosis Lifestyle FAQ

At a Glance

HIV-1 pre-exposure prophylaxis is a preventive medication strategy used by HIV-negative individuals to significantly reduce their risk of acquiring HIV infection through sexual contact or injection drug use by blocking the virus from replicating in the body's immune cells.
This preventive treatment is prescribed to sexually active adolescents and adults of any age who are considered at risk for HIV acquisition, with usage steadily increasing among key populations.
It is an ongoing, manageable preventive regimen that requires strict adherence to a daily or scheduled dosing plan to remain effective.
The outlook for individuals taking this medication is excellent, as it reduces the risk of sexual HIV transmission by approximately 99% when taken as prescribed, allowing users to maintain their health and peace of mind.

See Your Ranked Personalized Treatments

A graphic depicting a sample medication report that registered members can run.
Impact in entire body.

How It Affects You

HIV-1 pre-exposure prophylaxis (PrEP) acts systemically throughout the body to prevent the Human Immunodeficiency Virus (HIV) from establishing a permanent infection. The medication works by blocking specific enzymes that the virus needs to replicate, effectively halting the spread of the virus if exposure occurs. While its primary effect is invisible (immune protection), it can cause temporary or long-term effects on specific organ systems in some individuals:

  • Digestive System: Mild nausea, upset stomach, or loss of appetite are common during the first few weeks of use.
  • Nervous System: Headaches and fatigue may occur as the body adjusts to the medication.
  • Kidneys and Bones: Long-term use of certain oral formulations may occasionally impact kidney function or bone density.
.

Causes and Risk Factors

Mechanism of Action
HIV-1 pre-exposure prophylaxis works by inhibiting the enzymes that HIV uses to copy itself and spread. When an individual takes the medication consistently, it builds up in the body's tissues. If they are exposed to HIV, the drug prevents the virus from converting its genetic material into a form that can integrate into the host's DNA. This blockage stops the virus from establishing a permanent infection in the body.

Indications and Risk Factors
This medication is not a treatment for an existing disease but a prevention method for those at high risk of exposure. Clinicians recommend it for HIV-negative adults and adolescents who have an HIV-positive sexual partner, have multiple partners with unknown HIV status, do not regularly use condoms, or have been diagnosed with a sexually transmitted infection in the past six months. It is also recommended for people who inject drugs and share injection equipment. Unlike genetic or environmental causes of disease, the "cause" for using this medication is behavioral or situational risk of viral exposure.

Prevention Strategy
The medication itself is a form of primary prevention. To ensure it works, the primary requirement is adherence. Taking the medication exactly as prescribed—whether it is a daily pill or a scheduled injection—is the most critical step in preventing HIV. It does not prevent other sexually transmitted infections (STIs) or pregnancy. Therefore, it is often used as part of a combination prevention strategy that may include condoms, regular testing, and safer sex practices to reduce the severity of overall health risks.

A graphic depicting a sample medication report that registered members can run.
.

Diagnosis, Signs, and Symptoms

Determining Eligibility
Before starting HIV-1 pre-exposure prophylaxis, clinicians must confirm that an individual is HIV-negative. This is the most critical step in the "diagnosis" of eligibility. Starting this medication while unknowingly infected with HIV can lead to the virus developing resistance to treatment. Providers use highly sensitive blood tests (antigen/antibody tests or RNA tests) to screen for both established and acute (very recent) HIV infections. They also assess kidney function through blood tests, as some oral formulations are processed by the kidneys, and screen for Hepatitis B, because the medication can affect how that virus behaves.

Signs of Seroconversion
While the medication itself prevents infection, users must be aware of the signs of acute HIV infection, often called seroconversion. If the prevention fails—usually due to missed doses—or if a person was infected just before starting, they may experience flu-like symptoms. These include fever, fatigue, swollen lymph nodes, sore throat, rash, and muscle or joint pain. Experiencing these symptoms while on the medication requires immediate medical attention and testing to rule out a breakthrough infection.

Side Effects vs. Symptoms
Most people tolerate the medication well, but some experience side effects that can be mistaken for symptoms of an illness. Common early side effects include nausea, headache, and stomach pain. These usually subside within a few weeks, known as the "startup syndrome." Unlike disease symptoms which worsen over time, these side effects typically improve as the body adapts to the drug.

.

Treatment and Management

Medication Options
There are currently two main types of administration for HIV-1 pre-exposure prophylaxis: daily oral tablets and long-acting injections. Oral options include combinations of antiviral drugs that must be taken once every day to maintain protective levels in the body. The injectable option is administered by a healthcare professional every two months after an initial initiation period. The choice of medication depends on the individual's sex, risk factors, and potential for side effects. For example, certain oral tablets are not yet approved for those at risk through receptive vaginal sex.

Monitoring and Management
Management involves regular follow-up appointments, typically every three months. During these visits, clinicians repeat HIV tests to ensure the user remains negative. They also screen for other sexually transmitted infections (STIs) like syphilis, gonorrhea, and chlamydia, as the medication does not protect against these. Kidney function is monitored periodically for those on oral regimens. This routine monitoring allows for the early detection of any complications or adherence issues.

When to Seek Medical Care
Users should contact their healthcare provider immediately if they miss multiple doses or suspect they have been exposed to HIV during a period of non-adherence. Emergency care or immediate consultation is necessary if flu-like symptoms appear, as these could indicate an acute HIV infection. Additionally, if side effects such as severe abdominal pain, yellowing of the skin or eyes, or dark urine occur, medical evaluation is needed to rule out rare liver or kidney reactions.

A graphic depicting a sample medication report that registered members can run.
.

Severity and Prognosis

Effectiveness and Outcomes
The "prognosis" for individuals taking HIV-1 pre-exposure prophylaxis is excellent regarding HIV prevention. When taken consistently, daily oral medication reduces the risk of getting HIV from sex by about 99% and from injection drug use by at least 74%. The injectable form has shown even higher efficacy in some clinical trials, likely due to the removal of daily adherence barriers. However, effectiveness drops significantly when doses are missed, emphasizing that the severity of risk is directly tied to adherence behavior.

Duration and Course
This is not a permanent cure or a lifelong requirement for everyone; it is used during "seasons of risk." An individual may take it for a few months or several years, depending on their relationship status and sexual behavior. It can be started and stopped under medical guidance. When stopping, specific protocols must be followed to ensure no residual risk of infection from recent exposures.

Complications and Risks
While generally safe, there are potential complications. Short-term effects include gastrointestinal distress and headaches. Long-term use of certain oral formulations has been associated with a small decrease in bone mineral density and mild decreases in kidney function. These changes are typically reversible upon stopping the medication. Serious, life-threatening reactions are extremely rare. The medication does not negatively impact overall life expectancy; rather, it protects it by preventing a potentially life-altering chronic infection.

.

Impact on Daily Life

Incorporating into Routine
Taking a daily pill requires building a habit, such as pairing the medication with brushing teeth or eating breakfast. For those using the injectable form, managing appointments every two months is necessary. Users report that the medication provides a significant sense of security and empowerment, reducing anxiety related to sexual intimacy and HIV transmission. It allows for a healthier, less fearful approach to relationships and dating.

Coping with Stigma
Some individuals may face judgment or stigma from family, peers, or healthcare providers who misunderstand the purpose of the medication, sometimes incorrectly associating it with promiscuity. Connecting with supportive communities, online forums, or inclusive healthcare providers can help mitigate these emotional challenges. Many users view the medication as a responsible and proactive health decision.

Questions to Ask Your Healthcare Provider
To ensure the best care and understanding, consider asking these questions:

  • Which formulation (pill or shot) is best for my specific lifestyle and risk factors?
  • How often do I need to come in for lab tests, and what exactly are you testing for?
  • What should I do if I miss a dose or run out of medication?
  • Are there any over-the-counter drugs or supplements I should avoid while on this medication?
  • How long do I need to take this medication before I am fully protected?
A graphic depicting a sample medication report that registered members can run.
.

Common Questions and Answers

Q: Does this medication protect against other sexually transmitted infections (STIs)?
A: No. It only protects against HIV. It does not prevent gonorrhea, chlamydia, syphilis, or herpes. Condoms are recommended to reduce the risk of these other infections.

Q: Can I stop using condoms if I take this medication?
A: While the medication provides very high protection against HIV, it offers no protection against other STIs or unplanned pregnancy. Many people use condoms in combination with the medication for broader protection, but the decision depends on your personal risk factors and partner agreements.

Q: What happens if I miss a dose?
A: If you miss a daily pill, take it as soon as you remember. If it is almost time for your next dose, skip the missed one and continue your regular schedule. Do not double up. Frequent missed doses can significantly lower your protection.

Q: Is this medication the same as a vaccine?
A: No. A vaccine teaches the immune system to fight an infection for years or decades after a few shots. This is a medication that clears the virus if it enters the body, but it only works as long as you have enough of the drug in your system.

Q: Will taking this medication cause me to test positive for HIV?
A: No. The medication itself does not cause a positive result on standard HIV tests. However, if you become infected while taking it (which is rare), it might affect how some tests detect the virus, so accurate disclosure to your doctor is important.

Content last updated on February 12, 2026. Always consult a qualified health professional before making any treatment decisions or taking any medications. Review our Terms of Service for full details.